Heymach J, Opdam F, Barve M, Gibson N, et al. A Phase I, Open-Label, Dose Confirmation, Escalation, and Expansion Trial of BI 1810631 as Monotherapy in Patients With Advanced or Metastatic Solid Tumors With HER2 Aberrations. Clin Lung Cancer 2023;24:e65-e68.
PMID: 36528522